Kim Kelderman - Sep 22, 2021 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Pres. Diagnostics & Genom
Signature
/s/ Brenda S. Furlow as Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed.
Stock symbol
TECH
Transactions as of
Sep 22, 2021
Transactions value $
-$434,871
Form type
4
Date filed
9/24/2021, 04:30 PM
Previous filing
Aug 10, 2021
Next filing
Nov 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Sale -$435K -822 -100% $529.04* 0 Sep 22, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TECH Stock Options (Right to Buy) 2.65K Sep 22, 2021 Common Stock 2.65K $150.78 Direct F2
holding TECH Stock Options (Right to Buy) 7.35K Sep 22, 2021 Common Stock 7.35K $150.78 Direct F3
holding TECH Stock Options (Right to Buy) 12K Sep 22, 2021 Common Stock 12K $177.32 Direct F4
holding TECH Stock Options (Right to Buy) 9.03K Sep 22, 2021 Common Stock 9.03K $177.32 Direct F5
holding TECH Restricted Stock Units 2.36K Sep 22, 2021 Common Stock 2.36K Direct F6, F7
holding TECH Stock Options (Right to Buy) 12K Sep 22, 2021 Common Stock 12K $190.41 Direct F7
holding TECH Stock Options (Right to Buy) 15.9K Sep 22, 2021 Common Stock 15.9K $190.41 Direct F8
holding TECH Restricted Stock Units 2.02K Sep 22, 2021 Common Stock 2.02K Direct F6, F9
holding TECH Stock Options (Right to Buy) 8.99K Sep 22, 2021 Common Stock 8.99K $267.87 Direct F9
holding TECH Stock Options (Right to Buy) 12K Sep 22, 2021 Common Stock 12K $267.87 Direct F10
holding TECH Stock Options (Right to Buy) 8.33K Sep 22, 2021 Common Stock 8.33K $267.87 Direct F11
holding TECH Stock Options (Right to Buy) 8.33K Sep 22, 2021 Common Stock 8.33K $267.87 Direct F12
holding TECH Restricted Stock Units 1.25K Sep 22, 2021 Common Stock 1.25K Direct F6, F13
holding TECH Stock Options (Right to Buy) 4.86K Sep 22, 2021 Common Stock 4.86K $481.82 Direct F13
holding TECH Stock Options (Right to Buy) 6.49K Sep 22, 2021 Common Stock 6.49K $481.82 Direct F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2021.
F2 Options to purchase 663 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022.
F3 Options to purchase 1,837 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022.
F4 Options to purchase 3,011 shares vest on each of 8/8/2019, 8/8/2020, 8/8/2021 and 8/8/2022.
F5 Fully exercisable.
F6 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F7 Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8 Options to purchase 3,987 shares vest on each of 8/7/2020, 8/7/2021, 8/7/2022 and 8/7/2023.
F9 Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F10 Options to purchase 2,997 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.
F11 Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
F12 Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
F13 Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F14 Options to purchase 1,621 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 1,622 shares vest on each of 8/6/2024 and 8/6/2025.